Clinical trial
Double-Blind Placebo-Controlled Study of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients
NCT00410930 is registered in ClinicalTrials.gov with Stallergenes Greer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind Placebo-Controlled Study of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients
- Lead sponsor
- Stallergenes Greer
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2002
- Completion date
- November 30, 2005
- Enrollment
- 160
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergy